Press Releases Tempus AI, Inc

Equities

Real-time Estimate Cboe BZX Other stock markets 17:15:14 01/07/2024 BST			5-day change	1st Jan Change
32.34 ^USD	-7.60%		+29.20%	0.00%

06-28	Biopharma firm Alumis' shares fall nearly 16% in Nasdaq debut	RE
06-27	SoftBank Group to Form Joint Venture with Tempus AI	CI

Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-AF, an AI-based Algorithm that Identifies Patients at Increased Risk of AFib	06-26	BU
Tempus Announces Collaboration with United Therapeutics to Study Use of AI to Detect Patients at Risk for Pulmonary Hypertension	06-26	AQ
Tempus Announces Pricing of Initial Public Offering	06-13	BU

No results for this search